封面
市场调查报告书
商品编码
1608147

术中神经监测市场:按类型、方式和应用划分 - 全球预测 2025-2030

Intraoperative Neuromonitoring Market by Type (Insource IONM, Outsource IONM), Modality (Brainstem Auditory Evoked Potentials, Electroencephalography, Electromyography), Application - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

术中神经监测市场2023年估值为31.3亿美元,预计到2024年将达到33.1亿美元,复合年增长率为5.69%,到2030年达到46.2亿美元。

术中神经监测 (IONM) 是手术期间使用的一种专门程序,用于即时监测神经通路并降低神经或脊髓损伤的风险。对 IONM 的需求源于其能够向外科医生提供即时回馈并提高患者安全性,特别是在涉及大脑、脊椎和神经的复杂手术期间。 IONM具有广泛的应用范围,包括整形外科、神经外科、血管外科和耳鼻喉科。最终用途包括医院、手术中心和专科诊所,手术量的增加和尽量减少手术併发症的愿望推动了需求。

主要市场统计
基准年[2023] 31.3亿美元
预计年份 [2024] 33.1亿美元
预测年份 [2030] 46.2亿美元
复合年增长率(%) 5.69%

市场洞察揭示了影响成长的几个关键因素,包括技术进步、需要更多手术的人口老化以及医疗保健专业人员对患者安全意识的提高。随着医疗基础设施的不断扩大以及人工智慧和机器学习的集成,新兴市场的机会比比皆是,以提高监测准确性和预测分析。为了抓住这些机会,企业应专注于扩大在这些地区的业务,并投资于更复杂、更易于使用的设备的研发。

阻碍市场成长的挑战包括设备成本高、缺乏熟练的专业人员来操作 IONM 技术以及复杂的监管障碍。此外,技术创新的快节奏要求医疗保健提供者不断适应,这可能会造成采用障碍。

创新应着重于开发具有成本效益的解决方案,并增强无线连接和与其他手术系统的互通性。探索非侵入式监控技术可以为业务成长开闢新的途径。 IONM 市场的本质是动态的,其特点是不断的技术创新和竞争格局。为了保持竞争力,公司应优先考虑策略伙伴关係、持续的技术更新以及针对医疗保健专业人员的全面培训计划。透过积极应对这些挑战并利用新技术,公司可以加速成长并扩大市场份额。

市场动态:快速发展的术中神经监测市场的关键市场洞察

供需的动态交互作用正在改变术中神经监测市场。透过了解这些不断变化的市场动态,公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 与各种生活方式相关的慢性病盛行率增加
    • 优惠的报销政策和更安全的手术需求
    • 外包和术中神经监测的趋势不断增加
  • 市场限制因素
    • 治疗费用上涨
  • 市场机会
    • 神经监测技术进步可最大程度地降低手术过程中的风险
    • 政府机构加大研发投入
  • 市场挑战
    • 缺乏熟练的专业人员和意识低

波特五力:驾驭术中神经监测市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解术中神经监测市场的外部影响

外部宏观环境因素在塑造术中神经监测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。

市场占有率分析 了解术中神经监测市场的竞争状况

对术中神经监测市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵术中神经监测市场供应商的绩效评估

FPNV 定位矩阵是评估术中神经监测市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商,从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了术中神经监测市场的成功之路

对于旨在加强在全球市场的影响力的公司来说,术中神经监测市场的策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 与不同生活方式相关的慢性病增加
      • 要求优惠的报销政策和更安全的手术方法
      • 外包术中神经监测的趋势不断增加
    • 抑制因素
      • 治疗费用高
    • 机会
      • 神经监测技术进步可最大程度地降低手术过程中的风险
      • 政府机构加大研发投入
    • 任务
      • 缺乏熟练的专业人员和意识低
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章术中神经监测市场:依类型

  • 内源IONM
  • 外包 IONM

第七章术中神经监测市场:依方式

  • 脑干听觉诱发电位
  • 脑电图测试
  • 肌电图
  • 运动诱发电位
  • 体感诱发电位
  • 视觉诱发电位

第八章术中神经监测市场:依应用分类

  • 耳鼻喉科手术
  • 神经外科
  • 整形外科
  • 脊椎手术
  • 血管外科

第九章北美和南美的术中神经监测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区术中神经监测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的术中神经监测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Accurate Monitoring, LLC
  • Argos Neuromonitoring LP
  • Biotronic NeuroNetwork, LLC
  • Cadwell Industries, Inc.
  • Computational Diagnostics, Inc.
  • Emotiv Inc.
  • inomed Medizintechnik GmbH
  • Intranerve, LLC
  • Medsurant Health
  • Medtronic PLC
  • Moberg Research Inc.
  • Natus Medical Incorporated
  • NeuroMonitoring Technologies
  • NeuroSentinel LLC
  • Nihon Kohden Corporation
  • NuVasive Inc
  • Procirca
  • ProPep Surgical
  • SpecialtyCare, Inc.
Product Code: MRR-AD36CD8980BB

The Intraoperative Neuromonitoring Market was valued at USD 3.13 billion in 2023, expected to reach USD 3.31 billion in 2024, and is projected to grow at a CAGR of 5.69%, to USD 4.62 billion by 2030.

Intraoperative neuromonitoring (IONM) is a specialized procedure used during surgeries to monitor the neural pathways in real-time, reducing the risk of nerve or spinal cord damage. The necessity of IONM stems from its ability to provide immediate feedback to surgeons, enhancing patient safety, particularly during complex surgeries involving the brain, spine, and nerves. Its applications are broad, spanning orthopedic, neurosurgical, vascular, and ENT procedures. The end-use scope includes hospitals, surgical centers, and specialty clinics, where demand is driven by the increasing volume of surgeries and the desire to minimize surgical complications.

KEY MARKET STATISTICS
Base Year [2023] USD 3.13 billion
Estimated Year [2024] USD 3.31 billion
Forecast Year [2030] USD 4.62 billion
CAGR (%) 5.69%

Market insights reveal several key factors influencing growth, including technological advancements, an aging population requiring more surgeries, and increasing awareness among healthcare professionals about patient safety benefits. Opportunities abound in emerging markets, where healthcare infrastructure is expanding, and in the integration of artificial intelligence and machine learning to enhance monitoring accuracy and predictive analytics. To seize these opportunities, companies should focus on expanding their presence in these regions and investing in R&D for more sophisticated, user-friendly devices.

Challenges impeding market growth include high equipment costs, a shortage of skilled professionals to operate IONM technologies, and complex regulatory hurdles. Furthermore, the rapid pace of technological change demands constant adaptation by healthcare providers, which can be a barrier for widespread adoption.

Innovation should concentrate on developing cost-effective solutions and enhancing wireless connectivity and interoperability with other surgical systems. Research into non-invasive monitoring techniques could offer new avenues for business growth. The nature of the IONM market is dynamic, characterized by continuous technological innovations and a competitive landscape. Businesses should prioritize strategic partnerships, continuous technological updates, and comprehensive training programs for healthcare professionals to maintain a competitive edge. By being proactive in addressing these challenges and leveraging new technologies, businesses can drive growth and establish a strong market presence.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intraoperative Neuromonitoring Market

The Intraoperative Neuromonitoring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of various lifestyles associated chronic diseases
    • Favorable reimbursement policies and demand for safer surgery practices
    • Rising trend of outsourcing Intraoperative Neuromonitoring
  • Market Restraints
    • High cost of treatment
  • Market Opportunities
    • Technological advancements in neuromonitoring to minimize the risks during surgery
    • Increased R&D investments by governmental bodies
  • Market Challenges
    • Dearth of skilled professionals and low awareness

Porter's Five Forces: A Strategic Tool for Navigating the Intraoperative Neuromonitoring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intraoperative Neuromonitoring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intraoperative Neuromonitoring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intraoperative Neuromonitoring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intraoperative Neuromonitoring Market

A detailed market share analysis in the Intraoperative Neuromonitoring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intraoperative Neuromonitoring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intraoperative Neuromonitoring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intraoperative Neuromonitoring Market

A strategic analysis of the Intraoperative Neuromonitoring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intraoperative Neuromonitoring Market, highlighting leading vendors and their innovative profiles. These include Accurate Monitoring, LLC, Argos Neuromonitoring LP, Biotronic NeuroNetwork, LLC, Cadwell Industries, Inc., Computational Diagnostics, Inc., Emotiv Inc., inomed Medizintechnik GmbH, Intranerve, LLC, Medsurant Health, Medtronic PLC, Moberg Research Inc., Natus Medical Incorporated, NeuroMonitoring Technologies, NeuroSentinel LLC, Nihon Kohden Corporation, NuVasive Inc, Procirca, ProPep Surgical, and SpecialtyCare, Inc..

Market Segmentation & Coverage

This research report categorizes the Intraoperative Neuromonitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Insource IONM and Outsource IONM.
  • Based on Modality, market is studied across Brainstem Auditory Evoked Potentials, Electroencephalography, Electromyography, Motor Evoked Potentials, Somatosensory Evoked Potentials, and Visual Evoked Potentials.
  • Based on Application, market is studied across ENT Surgery, Neurosurgery, Orthopedic Surgery, Spinal Surgery, and Vascular Surgery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of various lifestyles associated chronic diseases
      • 5.1.1.2. Favorable reimbursement policies and demand for safer surgery practices
      • 5.1.1.3. Rising trend of outsourcing Intraoperative Neuromonitoring
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in neuromonitoring to minimize the risks during surgery
      • 5.1.3.2. Increased R&D investments by governmental bodies
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professionals and low awareness
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intraoperative Neuromonitoring Market, by Type

  • 6.1. Introduction
  • 6.2. Insource IONM
  • 6.3. Outsource IONM

7. Intraoperative Neuromonitoring Market, by Modality

  • 7.1. Introduction
  • 7.2. Brainstem Auditory Evoked Potentials
  • 7.3. Electroencephalography
  • 7.4. Electromyography
  • 7.5. Motor Evoked Potentials
  • 7.6. Somatosensory Evoked Potentials
  • 7.7. Visual Evoked Potentials

8. Intraoperative Neuromonitoring Market, by Application

  • 8.1. Introduction
  • 8.2. ENT Surgery
  • 8.3. Neurosurgery
  • 8.4. Orthopedic Surgery
  • 8.5. Spinal Surgery
  • 8.6. Vascular Surgery

9. Americas Intraoperative Neuromonitoring Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intraoperative Neuromonitoring Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intraoperative Neuromonitoring Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accurate Monitoring, LLC
  • 2. Argos Neuromonitoring LP
  • 3. Biotronic NeuroNetwork, LLC
  • 4. Cadwell Industries, Inc.
  • 5. Computational Diagnostics, Inc.
  • 6. Emotiv Inc.
  • 7. inomed Medizintechnik GmbH
  • 8. Intranerve, LLC
  • 9. Medsurant Health
  • 10. Medtronic PLC
  • 11. Moberg Research Inc.
  • 12. Natus Medical Incorporated
  • 13. NeuroMonitoring Technologies
  • 14. NeuroSentinel LLC
  • 15. Nihon Kohden Corporation
  • 16. NuVasive Inc
  • 17. Procirca
  • 18. ProPep Surgical
  • 19. SpecialtyCare, Inc.

LIST OF FIGURES

  • FIGURE 1. INTRAOPERATIVE NEUROMONITORING MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INTRAOPERATIVE NEUROMONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INTRAOPERATIVE NEUROMONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRAOPERATIVE NEUROMONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTRAOPERATIVE NEUROMONITORING MARKET DYNAMICS
  • TABLE 7. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY INSOURCE IONM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY OUTSOURCE IONM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY BRAINSTEM AUDITORY EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ELECTROMYOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MOTOR EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY SOMATOSENSORY EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY VISUAL EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ENT SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. INTRAOPERATIVE NEUROMONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. INTRAOPERATIVE NEUROMONITORING MARKET, FPNV POSITIONING MATRIX, 2023